List of Tables
Table 1. Global VEGFR-2 Inhibitor Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global VEGFR-2 Inhibitor Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global VEGFR-2 Inhibitor Market Competitive Situation by Manufacturers in 2025
Table 4. Global VEGFR-2 Inhibitor Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global VEGFR-2 Inhibitor Sales Market Share by Manufacturers (2021–2026)
Table 6. Global VEGFR-2 Inhibitor Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global VEGFR-2 Inhibitor Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market VEGFR-2 Inhibitor Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of VEGFR-2 Inhibitor, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of VEGFR-2 Inhibitor, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of VEGFR-2 Inhibitor, Product Types and Applications
Table 12. Global Key Manufacturers of VEGFR-2 Inhibitor, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global VEGFR-2 Inhibitor Companies by Tier (Tier 1, Tier 2, Tier 3), based on VEGFR-2 Inhibitor Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global VEGFR-2 Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global VEGFR-2 Inhibitor Sales by Region (K Units), 2021–2026
Table 18. Global VEGFR-2 Inhibitor Sales Market Share by Region (2021–2026)
Table 19. Global VEGFR-2 Inhibitor Sales by Region (K Units), 2027–2032
Table 20. Global VEGFR-2 Inhibitor Sales Market Share by Region (2027–2032)
Table 21. Global VEGFR-2 Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 22. Global VEGFR-2 Inhibitor Revenue Market Share by Region (2021–2026)
Table 23. Global VEGFR-2 Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 24. Global VEGFR-2 Inhibitor Revenue Market Share by Region (2027–2032)
Table 25. North America VEGFR-2 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America VEGFR-2 Inhibitor Sales by Country (K Units), 2021–2026
Table 27. North America VEGFR-2 Inhibitor Sales by Country (K Units), 2027–2032
Table 28. North America VEGFR-2 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 29. North America VEGFR-2 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 30. Europe VEGFR-2 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe VEGFR-2 Inhibitor Sales by Country (K Units), 2021–2026
Table 32. Europe VEGFR-2 Inhibitor Sales by Country (K Units), 2027–2032
Table 33. Europe VEGFR-2 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 34. Europe VEGFR-2 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific VEGFR-2 Inhibitor Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific VEGFR-2 Inhibitor Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific VEGFR-2 Inhibitor Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific VEGFR-2 Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific VEGFR-2 Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America VEGFR-2 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America VEGFR-2 Inhibitor Sales by Country (K Units), 2021–2026
Table 42. Latin America VEGFR-2 Inhibitor Sales by Country (K Units), 2027–2032
Table 43. Latin America VEGFR-2 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America VEGFR-2 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa VEGFR-2 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa VEGFR-2 Inhibitor Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa VEGFR-2 Inhibitor Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa VEGFR-2 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa VEGFR-2 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 50. Global VEGFR-2 Inhibitor Sales (K Units) by Type (2021–2026)
Table 51. Global VEGFR-2 Inhibitor Sales (K Units) by Type (2027–2032)
Table 52. Global VEGFR-2 Inhibitor Sales Market Share by Type (2021–2026)
Table 53. Global VEGFR-2 Inhibitor Sales Market Share by Type (2027–2032)
Table 54. Global VEGFR-2 Inhibitor Revenue (US$ Million) by Type (2021–2026)
Table 55. Global VEGFR-2 Inhibitor Revenue (US$ Million) by Type (2027–2032)
Table 56. Global VEGFR-2 Inhibitor Revenue Market Share by Type (2021–2026)
Table 57. Global VEGFR-2 Inhibitor Revenue Market Share by Type (2027–2032)
Table 58. Global VEGFR-2 Inhibitor Price (US$/Unit) by Type (2021–2026)
Table 59. Global VEGFR-2 Inhibitor Price (US$/Unit) by Type (2027–2032)
Table 60. Global VEGFR-2 Inhibitor Sales (K Units) by Application (2021–2026)
Table 61. Global VEGFR-2 Inhibitor Sales (K Units) by Application (2027–2032)
Table 62. Global VEGFR-2 Inhibitor Sales Market Share by Application (2021–2026)
Table 63. Global VEGFR-2 Inhibitor Sales Market Share by Application (2027–2032)
Table 64. Global VEGFR-2 Inhibitor Revenue (US$ Million) by Application (2021–2026)
Table 65. Global VEGFR-2 Inhibitor Revenue (US$ Million) by Application (2027–2032)
Table 66. Global VEGFR-2 Inhibitor Revenue Market Share by Application (2021–2026)
Table 67. Global VEGFR-2 Inhibitor Revenue Market Share by Application (2027–2032)
Table 68. Global VEGFR-2 Inhibitor Price (US$/Unit) by Application (2021–2026)
Table 69. Global VEGFR-2 Inhibitor Price (US$/Unit) by Application (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer VEGFR-2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bayer VEGFR-2 Inhibitor Product
Table 74. Bayer Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer VEGFR-2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer VEGFR-2 Inhibitor Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Jiangsu Hengrui Pharmaceuticals Company Information
Table 81. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 82. Jiangsu Hengrui Pharmaceuticals VEGFR-2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Jiangsu Hengrui Pharmaceuticals VEGFR-2 Inhibitor Product
Table 84. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 85. Chia Tai Tianqing Company Information
Table 86. Chia Tai Tianqing Description and Business Overview
Table 87. Chia Tai Tianqing VEGFR-2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Chia Tai Tianqing VEGFR-2 Inhibitor Product
Table 89. Chia Tai Tianqing Recent Developments/Updates
Table 90. Novartis Company Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis VEGFR-2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Novartis VEGFR-2 Inhibitor Product
Table 94. Novartis Recent Developments/Updates
Table 95. AstraZeneca Company Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca VEGFR-2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. AstraZeneca VEGFR-2 Inhibitor Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Exelixis Company Information
Table 101. Exelixis Description and Business Overview
Table 102. Exelixis VEGFR-2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Exelixis VEGFR-2 Inhibitor Product
Table 104. Exelixis Recent Developments/Updates
Table 105. Boehringer Ingelheim Company Information
Table 106. Boehringer Ingelheim Description and Business Overview
Table 107. Boehringer Ingelheim VEGFR-2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Boehringer Ingelheim VEGFR-2 Inhibitor Product
Table 109. Boehringer Ingelheim Recent Developments/Updates
Table 110. Eisai Company Information
Table 111. Eisai Description and Business Overview
Table 112. Eisai VEGFR-2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Eisai VEGFR-2 Inhibitor Product
Table 114. Eisai Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. VEGFR-2 Inhibitor Distributors List
Table 118. VEGFR-2 Inhibitor Customers List
Table 119. VEGFR-2 Inhibitor Market Trends
Table 120. VEGFR-2 Inhibitor Market Drivers
Table 121. VEGFR-2 Inhibitor Market Challenges
Table 122. VEGFR-2 Inhibitor Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of VEGFR-2 Inhibitor
Figure 2. Global VEGFR-2 Inhibitor Market Value by Type (US$ Million), 2021–2032
Figure 3. Global VEGFR-2 Inhibitor Market Share by Type: 2025 & 2032
Figure 4. Sorafenib Product Picture
Figure 5. Sunitinib Product Picture
Figure 6. Lenvatinib Product Picture
Figure 7. Vandetanib Product Picture
Figure 8. Cabozantinib Product Picture
Figure 9. Nintedanib Product Picture
Figure 10. Apatinib Product Picture
Figure 11. Other Product Picture
Figure 12. Global VEGFR-2 Inhibitor Market Value by Application (US$ Million), 2021–2032
Figure 13. Global VEGFR-2 Inhibitor Market Share by Application: 2025 & 2032
Figure 14. Cancer Therapy
Figure 15. Ophthalmic Diseases
Figure 16. Other
Figure 17. Global VEGFR-2 Inhibitor Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global VEGFR-2 Inhibitor Market Size (US$ Million), 2021–2032
Figure 19. Global VEGFR-2 Inhibitor Sales (K Units), 2021–2032
Figure 20. Global VEGFR-2 Inhibitor Average Price (US$/Unit), 2021–2032
Figure 21. VEGFR-2 Inhibitor Report Years Considered
Figure 22. VEGFR-2 Inhibitor Sales Share by Manufacturers in 2025
Figure 23. Global VEGFR-2 Inhibitor Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global VEGFR-2 Inhibitor Players: Market Share by Revenue in VEGFR-2 Inhibitor in 2025
Figure 25. VEGFR-2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global VEGFR-2 Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America VEGFR-2 Inhibitor Sales Market Share by Country (2021–2032)
Figure 28. North America VEGFR-2 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 29. United States VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe VEGFR-2 Inhibitor Sales Market Share by Country (2021–2032)
Figure 32. Europe VEGFR-2 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 33. Germany VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific VEGFR-2 Inhibitor Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific VEGFR-2 Inhibitor Revenue Market Share by Region (2021–2032)
Figure 40. China VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. China Taiwan VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Southeast Asia VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America VEGFR-2 Inhibitor Sales Market Share by Country (2021–2032)
Figure 48. Latin America VEGFR-2 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 49. Mexico VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Colombia VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa VEGFR-2 Inhibitor Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa VEGFR-2 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 55. Turkey VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. UAE VEGFR-2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of VEGFR-2 Inhibitor by Type (2021–2032)
Figure 59. Global Revenue Market Share of VEGFR-2 Inhibitor by Type (2021–2032)
Figure 60. Global VEGFR-2 Inhibitor Price (US$/Unit) by Type (2021–2032)
Figure 61. Global Sales Market Share of VEGFR-2 Inhibitor by Application (2021–2032)
Figure 62. Global Revenue Market Share of VEGFR-2 Inhibitor by Application (2021–2032)
Figure 63. Global VEGFR-2 Inhibitor Price (US$/Unit) by Application (2021–2032)
Figure 64. VEGFR-2 Inhibitor Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
